申请人:SMITHKLINE BEECHAM CORP
公开号:WO2004032856A2
公开(公告)日:2004-04-22
Oxazolidin-2-one of the formula as further defined herein are useful for inhibiting the chemokine receptor nominated CCR8, resulting in treatment of diseases such as asthma and the like.